Rank | Gene Set | Z-score |
---|---|---|
1 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 9.38697111 |
2 | regulation of chemokine secretion (GO:0090196) | 8.15970643 |
3 | macrophage activation involved in immune response (GO:0002281) | 7.69234951 |
4 | regulation of interferon-beta biosynthetic process (GO:0045357) | 7.07712604 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 6.69238539 |
6 | modulation by symbiont of host defense response (GO:0052031) | 6.69238539 |
7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.69238539 |
8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.69238539 |
9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.69238539 |
10 | modulation by symbiont of host immune response (GO:0052553) | 6.69238539 |
11 | negative regulation of granulocyte differentiation (GO:0030853) | 6.56548258 |
12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.49835239 |
13 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 6.35002977 |
14 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 6.07912358 |
15 | macrophage activation (GO:0042116) | 6.00359256 |
16 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.69298958 |
17 | adenosine receptor signaling pathway (GO:0001973) | 5.24758555 |
18 | purinergic receptor signaling pathway (GO:0035587) | 4.91062199 |
19 | monocyte differentiation (GO:0030224) | 4.64354367 |
20 | positive regulation of interferon-alpha production (GO:0032727) | 4.52657711 |
21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.50537661 |
22 | * glycosphingolipid catabolic process (GO:0046479) | 4.46058542 |
23 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.36053156 |
24 | I-kappaB phosphorylation (GO:0007252) | 4.31070968 |
25 | mannose metabolic process (GO:0006013) | 4.26869565 |
26 | regulation of interferon-alpha production (GO:0032647) | 4.26866541 |
27 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.16565318 |
28 | response to host (GO:0075136) | 4.16565318 |
29 | response to host defenses (GO:0052200) | 4.16565318 |
30 | macrophage differentiation (GO:0030225) | 4.16070437 |
31 | amino sugar catabolic process (GO:0046348) | 4.10035583 |
32 | negative regulation of tissue remodeling (GO:0034104) | 4.07064557 |
33 | negative regulation of norepinephrine secretion (GO:0010700) | 4.06519982 |
34 | ruffle organization (GO:0031529) | 4.04682729 |
35 | * glycolipid catabolic process (GO:0019377) | 4.02235444 |
36 | myeloid cell activation involved in immune response (GO:0002275) | 3.99323485 |
37 | response to host immune response (GO:0052572) | 3.98981431 |
38 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.98981431 |
39 | positive regulation of B cell differentiation (GO:0045579) | 3.98706177 |
40 | response to thyroid hormone (GO:0097066) | 3.96070465 |
41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.95800613 |
42 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 3.91366660 |
43 | barbed-end actin filament capping (GO:0051016) | 3.88821863 |
44 | cell-cell junction maintenance (GO:0045217) | 3.86767494 |
45 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.82766944 |
46 | germ cell migration (GO:0008354) | 3.80648925 |
47 | negative regulation of interleukin-6 production (GO:0032715) | 3.78776415 |
48 | regulation of mononuclear cell migration (GO:0071675) | 3.77240168 |
49 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.75278159 |
50 | negative regulation of interleukin-12 production (GO:0032695) | 3.73336415 |
51 | negative regulation of bone resorption (GO:0045779) | 3.73295156 |
52 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.73172270 |
53 | pinocytosis (GO:0006907) | 3.71290132 |
54 | * oligosaccharide catabolic process (GO:0009313) | 3.70533226 |
55 | sodium-independent organic anion transport (GO:0043252) | 3.70152718 |
56 | adaptation of signaling pathway (GO:0023058) | 3.68640224 |
57 | protein localization to endosome (GO:0036010) | 3.62501046 |
58 | macrophage chemotaxis (GO:0048246) | 3.57329114 |
59 | negative regulation of multicellular organism growth (GO:0040015) | 3.53964295 |
60 | regulation of macrophage chemotaxis (GO:0010758) | 3.51409084 |
61 | positive regulation of leukocyte degranulation (GO:0043302) | 3.51128640 |
62 | response to cholesterol (GO:0070723) | 3.49638342 |
63 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.38879834 |
64 | apoptotic cell clearance (GO:0043277) | 3.38662115 |
65 | * ceramide catabolic process (GO:0046514) | 3.37250570 |
66 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.37180814 |
67 | negative regulation of macrophage differentiation (GO:0045650) | 3.35661643 |
68 | cyclooxygenase pathway (GO:0019371) | 3.35264926 |
69 | phagocytosis, engulfment (GO:0006911) | 3.34897064 |
70 | negative regulation of cell killing (GO:0031342) | 3.32902464 |
71 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.32902464 |
72 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.32672428 |
73 | cellular extravasation (GO:0045123) | 3.31837268 |
74 | regulation of cholesterol storage (GO:0010885) | 3.28703671 |
75 | regulation of monocyte differentiation (GO:0045655) | 3.28290305 |
76 | peptide catabolic process (GO:0043171) | 3.27108400 |
77 | response to laminar fluid shear stress (GO:0034616) | 3.23386688 |
78 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.22678087 |
79 | regulation of antigen processing and presentation (GO:0002577) | 3.16223575 |
80 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.16086247 |
81 | tolerance induction (GO:0002507) | 3.15198088 |
82 | * membrane lipid catabolic process (GO:0046466) | 3.14214760 |
83 | adhesion of symbiont to host cell (GO:0044650) | 3.14028377 |
84 | virion attachment to host cell (GO:0019062) | 3.14028377 |
85 | detection of molecule of bacterial origin (GO:0032490) | 3.13679715 |
86 | positive regulation of interferon-beta production (GO:0032728) | 3.13555405 |
87 | response to muramyl dipeptide (GO:0032495) | 3.12898538 |
88 | regulation of granulocyte differentiation (GO:0030852) | 3.11798367 |
89 | myeloid leukocyte activation (GO:0002274) | 3.08403189 |
90 | positive regulation of chemokine production (GO:0032722) | 3.08071928 |
91 | respiratory burst (GO:0045730) | 3.06213161 |
92 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.01891117 |
93 | * sphingolipid catabolic process (GO:0030149) | 3.01488403 |
94 | regulation of actin cytoskeleton reorganization (GO:2000249) | 3.01218484 |
95 | negative regulation of B cell proliferation (GO:0030889) | 3.00974170 |
96 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.99968721 |
97 | receptor catabolic process (GO:0032801) | 2.99382313 |
98 | COPI coating of Golgi vesicle (GO:0048205) | 2.98062400 |
99 | Golgi transport vesicle coating (GO:0048200) | 2.98062400 |
100 | cell junction maintenance (GO:0034331) | 2.97917285 |
101 | adhesion of symbiont to host (GO:0044406) | 2.96673251 |
102 | regulation of monocyte chemotaxis (GO:0090025) | 2.96447140 |
103 | negative regulation of bone remodeling (GO:0046851) | 2.96031719 |
104 | N-acetylneuraminate metabolic process (GO:0006054) | 2.96002457 |
105 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.95545620 |
106 | cell adhesion mediated by integrin (GO:0033627) | 2.94554411 |
107 | regulation of bone resorption (GO:0045124) | 2.90695800 |
108 | immunoglobulin mediated immune response (GO:0016064) | 2.89923956 |
109 | response to sterol (GO:0036314) | 2.89516391 |
110 | regulation of leukocyte degranulation (GO:0043300) | 2.88238663 |
111 | regulation of superoxide anion generation (GO:0032928) | 2.86701407 |
112 | response to peptidoglycan (GO:0032494) | 2.81509312 |
113 | regulation of mast cell degranulation (GO:0043304) | 2.80664760 |
114 | regulation of T cell tolerance induction (GO:0002664) | 2.80358467 |
115 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.79490145 |
116 | regulation of extracellular matrix disassembly (GO:0010715) | 2.79403598 |
117 | response to acidic pH (GO:0010447) | 2.77511448 |
118 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.77359421 |
119 | neutrophil activation involved in immune response (GO:0002283) | 2.76599304 |
120 | cellular response to interleukin-6 (GO:0071354) | 2.76228116 |
121 | regulation of B cell differentiation (GO:0045577) | 2.74933135 |
122 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.74110607 |
123 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.73790824 |
124 | regulation of erythrocyte differentiation (GO:0045646) | 2.73160622 |
125 | T-helper 1 type immune response (GO:0042088) | 2.72153239 |
126 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.70284064 |
127 | low-density lipoprotein particle clearance (GO:0034383) | 2.67840515 |
128 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.65935425 |
129 | cellular response to arsenic-containing substance (GO:0071243) | 2.64927709 |
130 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.64788304 |
131 | angiotensin maturation (GO:0002003) | 2.63445771 |
132 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.63140392 |
133 | detection of external biotic stimulus (GO:0098581) | 2.62917294 |
134 | histamine secretion (GO:0001821) | 2.62634810 |
135 | negative regulation of smooth muscle contraction (GO:0045986) | 2.62404328 |
136 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.62403962 |
137 | positive regulation of mast cell degranulation (GO:0043306) | 2.62403962 |
138 | myeloid dendritic cell differentiation (GO:0043011) | 2.62021105 |
139 | vitamin D metabolic process (GO:0042359) | 2.60920299 |
140 | detection of other organism (GO:0098543) | 2.60425536 |
141 | dendritic cell differentiation (GO:0097028) | 2.58827437 |
142 | positive regulation of cholesterol efflux (GO:0010875) | 2.58461352 |
143 | B cell receptor signaling pathway (GO:0050853) | 2.56741357 |
144 | cortical actin cytoskeleton organization (GO:0030866) | 2.55330428 |
145 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.55091526 |
146 | iron ion import (GO:0097286) | 2.54631316 |
147 | positive regulation of extracellular matrix organization (GO:1903055) | 2.53438661 |
148 | membrane raft organization (GO:0031579) | 2.52382213 |
149 | * lytic vacuole organization (GO:0080171) | 2.52074036 |
150 | * lysosome organization (GO:0007040) | 2.52074036 |
151 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.51996495 |
152 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.51991951 |
153 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.50373494 |
154 | regulation of early endosome to late endosome transport (GO:2000641) | 2.50275664 |
155 | regulation of vitamin metabolic process (GO:0030656) | 2.49400697 |
156 | decidualization (GO:0046697) | 2.49048207 |
157 | regulation of podosome assembly (GO:0071801) | 2.48020107 |
158 | regulation of chemokine biosynthetic process (GO:0045073) | 2.47801929 |
159 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.46004304 |
160 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.45881678 |
161 | skin morphogenesis (GO:0043589) | 2.45371446 |
162 | phagosome maturation (GO:0090382) | 2.43106619 |
163 | eosinophil chemotaxis (GO:0048245) | 2.42332055 |
164 | positive regulation of mast cell activation (GO:0033005) | 2.41670984 |
165 | amyloid precursor protein catabolic process (GO:0042987) | 2.40677984 |
166 | osteoclast differentiation (GO:0030316) | 2.40152936 |
167 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.38705961 |
168 | * keratan sulfate catabolic process (GO:0042340) | 2.36372423 |
169 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.36215810 |
170 | phospholipid efflux (GO:0033700) | 2.35758516 |
171 | sphingosine metabolic process (GO:0006670) | 2.35540457 |
172 | protein retention in ER lumen (GO:0006621) | 2.34731440 |
173 | plasma lipoprotein particle clearance (GO:0034381) | 2.33061482 |
174 | positive regulation of cholesterol transport (GO:0032376) | 2.32862582 |
175 | positive regulation of sterol transport (GO:0032373) | 2.32862582 |
176 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.32724391 |
177 | granulocyte activation (GO:0036230) | 2.31992451 |
178 | positive regulation of interleukin-6 production (GO:0032755) | 2.29823130 |
179 | regulation of cholesterol esterification (GO:0010872) | 2.29391216 |
180 | * hyaluronan catabolic process (GO:0030214) | 2.29191167 |
181 | negative regulation of lipid storage (GO:0010888) | 2.28262246 |
182 | microglial cell activation (GO:0001774) | 10.8901925 |
183 | positive regulation of chemokine secretion (GO:0090197) | 10.5408294 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.44955644 |
2 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.67564122 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.42771739 |
4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.19694524 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.02883464 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.76247108 |
7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.64339303 |
8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.45230154 |
9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.40163198 |
10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.09798586 |
11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.84180212 |
12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.72499593 |
13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.71245179 |
14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.69382553 |
15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.47847509 |
16 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.45523770 |
17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.44224607 |
18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.42515622 |
19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34472997 |
20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.31972282 |
21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.31196873 |
22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.25458952 |
23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.06073367 |
24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.05403813 |
25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.04471741 |
26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.01458803 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.99200957 |
28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.98771760 |
29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.90072805 |
30 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.89836440 |
31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.84409653 |
32 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.84091590 |
33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.82051576 |
34 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.81651795 |
35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81636620 |
36 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77712310 |
37 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.75213175 |
38 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.74397473 |
39 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.70192688 |
40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.67923578 |
41 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.67784903 |
42 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.67784903 |
43 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.67784903 |
44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.66012988 |
45 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65782125 |
46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65540074 |
47 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.64494412 |
48 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.62683479 |
49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61171367 |
50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.58621410 |
51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.57980788 |
52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51125101 |
53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.49027215 |
54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.48016528 |
55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.45326386 |
56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45062845 |
57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44917357 |
58 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43068892 |
59 | MAF_26560356_Chip-Seq_TH1_Human | 1.39690695 |
60 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38034882 |
61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.36110660 |
62 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35094925 |
63 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.33832173 |
64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32577490 |
65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31973533 |
66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31744587 |
67 | MYC_22102868_ChIP-Seq_BL_Human | 1.30788008 |
68 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.30714702 |
69 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.30714702 |
70 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30439240 |
71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29834423 |
72 | MYB_26560356_Chip-Seq_TH2_Human | 1.29519657 |
73 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29113196 |
74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28967582 |
75 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27468482 |
76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27314706 |
77 | GATA2_19941826_ChIP-Seq_K562_Human | 1.27259141 |
78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27068686 |
79 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.26892366 |
80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.26001870 |
81 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21720532 |
82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21191581 |
83 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.21119770 |
84 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20875869 |
85 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.18039376 |
86 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16075067 |
87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15003359 |
88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13929010 |
89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12851141 |
90 | MYB_26560356_Chip-Seq_TH1_Human | 1.12040423 |
91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10597357 |
92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09768922 |
93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09416828 |
94 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09028444 |
95 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08743743 |
96 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07952279 |
97 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07058419 |
98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06478871 |
99 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06446116 |
100 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.05283537 |
101 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05037949 |
102 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04603139 |
103 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03466953 |
104 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03460750 |
105 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.03315632 |
106 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02256553 |
107 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01846091 |
108 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.00077941 |
109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99758486 |
110 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99284797 |
111 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99209124 |
112 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99198587 |
113 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98895663 |
114 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96774463 |
115 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96406603 |
116 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.96335147 |
117 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94906877 |
118 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93659106 |
119 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.93540723 |
120 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.93338140 |
121 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.92957735 |
122 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92838054 |
123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91756635 |
124 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86947494 |
125 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86584592 |
126 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86142954 |
127 | GATA3_26560356_Chip-Seq_TH2_Human | 0.84998208 |
128 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.82564405 |
129 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.81874947 |
130 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81421543 |
131 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80809484 |
132 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.80536493 |
133 | KDM2B_26808549_Chip-Seq_K562_Human | 0.79688304 |
134 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79575390 |
135 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78261189 |
136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78187563 |
137 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.78034363 |
138 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.77638274 |
139 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.77598373 |
140 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77149929 |
141 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76698160 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003191_abnormal_cellular_cholesterol | 6.02711477 |
2 | MP0005058_abnormal_lysosome_morphology | 5.43630946 |
3 | MP0003172_abnormal_lysosome_physiology | 4.63042298 |
4 | * MP0006082_CNS_inflammation | 3.50799320 |
5 | MP0001835_abnormal_antigen_presentation | 3.36215232 |
6 | MP0003303_peritoneal_inflammation | 3.29563122 |
7 | MP0003690_abnormal_glial_cell | 3.22005992 |
8 | MP0005671_abnormal_response_to | 3.19043435 |
9 | MP0005464_abnormal_platelet_physiology | 3.12190980 |
10 | MP0002139_abnormal_hepatobiliary_system | 2.97752596 |
11 | MP0003075_altered_response_to | 2.86513265 |
12 | MP0009840_abnormal_foam_cell | 2.85750052 |
13 | MP0002419_abnormal_innate_immunity | 2.48763890 |
14 | MP0008004_abnormal_stomach_pH | 2.40408496 |
15 | MP0002877_abnormal_melanocyte_morpholog | 2.28340472 |
16 | MP0005451_abnormal_body_composition | 2.19827788 |
17 | MP0003300_gastrointestinal_ulcer | 2.08448326 |
18 | MP0005257_abnormal_intraocular_pressure | 2.04659882 |
19 | MP0003183_abnormal_peptide_metabolism | 1.99832408 |
20 | MP0002148_abnormal_hypersensitivity_rea | 1.96943390 |
21 | * MP0002452_abnormal_antigen_presenting | 1.96576740 |
22 | MP0003436_decreased_susceptibility_to | 1.95737261 |
23 | MP0005000_abnormal_immune_tolerance | 1.93857599 |
24 | MP0006054_spinal_hemorrhage | 1.92397849 |
25 | MP0001533_abnormal_skeleton_physiology | 1.85848993 |
26 | MP0003252_abnormal_bile_duct | 1.81423108 |
27 | MP0005166_decreased_susceptibility_to | 1.80682125 |
28 | MP0003724_increased_susceptibility_to | 1.80678960 |
29 | MP0000343_altered_response_to | 1.78137030 |
30 | MP0005167_abnormal_blood-brain_barrier | 1.76146934 |
31 | * MP0002723_abnormal_immune_serum | 1.75057596 |
32 | MP0001851_eye_inflammation | 1.74796289 |
33 | MP0004883_abnormal_blood_vessel | 1.74721264 |
34 | MP0003806_abnormal_nucleotide_metabolis | 1.71411617 |
35 | MP0002928_abnormal_bile_duct | 1.67845782 |
36 | MP0003045_fibrosis | 1.64161710 |
37 | MP0003705_abnormal_hypodermis_morpholog | 1.58880163 |
38 | * MP0001819_abnormal_immune_cell | 1.58091315 |
39 | * MP0001800_abnormal_humoral_immune | 1.57101422 |
40 | MP0004185_abnormal_adipocyte_glucose | 1.54882672 |
41 | MP0000465_gastrointestinal_hemorrhage | 1.54450463 |
42 | * MP0002420_abnormal_adaptive_immunity | 1.52891800 |
43 | MP0005670_abnormal_white_adipose | 1.52214080 |
44 | MP0002090_abnormal_vision | 1.51905612 |
45 | MP0005025_abnormal_response_to | 1.48306230 |
46 | MP0001915_intracranial_hemorrhage | 1.46726475 |
47 | MP0002998_abnormal_bone_remodeling | 1.46448087 |
48 | MP0010234_abnormal_vibrissa_follicle | 1.45054163 |
49 | MP0003566_abnormal_cell_adhesion | 1.43880358 |
50 | MP0005365_abnormal_bile_salt | 1.43871041 |
51 | MP0008007_abnormal_cellular_replicative | 1.43007980 |
52 | MP0009764_decreased_sensitivity_to | 1.41778762 |
53 | MP0009333_abnormal_splenocyte_physiolog | 1.39421514 |
54 | MP0003329_amyloid_beta_deposits | 1.39259380 |
55 | MP0008260_abnormal_autophagy | 1.36463620 |
56 | * MP0008469_abnormal_protein_level | 1.35987083 |
57 | MP0001845_abnormal_inflammatory_respons | 1.31855354 |
58 | MP0009278_abnormal_bone_marrow | 1.31682545 |
59 | MP0003279_aneurysm | 1.28583034 |
60 | MP0000689_abnormal_spleen_morphology | 1.24392530 |
61 | MP0002396_abnormal_hematopoietic_system | 1.20681565 |
62 | MP0009384_cardiac_valve_regurgitation | 1.20600820 |
63 | MP0000716_abnormal_immune_system | 1.20452855 |
64 | MP0001542_abnormal_bone_strength | 1.20009878 |
65 | MP0000249_abnormal_blood_vessel | 1.17294405 |
66 | MP0002254_reproductive_system_inflammat | 1.16675858 |
67 | MP0004510_myositis | 1.15451686 |
68 | MP0000767_abnormal_smooth_muscle | 1.14168486 |
69 | MP0000920_abnormal_myelination | 1.13244280 |
70 | MP0009785_altered_susceptibility_to | 1.13048054 |
71 | MP0005023_abnormal_wound_healing | 1.11971905 |
72 | MP0005165_increased_susceptibility_to | 1.11418781 |
73 | MP0008873_increased_physiological_sensi | 1.10752311 |
74 | MP0003656_abnormal_erythrocyte_physiolo | 1.10257611 |
75 | MP0004272_abnormal_basement_membrane | 1.09029984 |
76 | MP0002405_respiratory_system_inflammati | 1.08780283 |
77 | MP0005310_abnormal_salivary_gland | 1.06586618 |
78 | MP0000685_abnormal_immune_system | 1.06205898 |
79 | MP0001790_abnormal_immune_system | 1.05168510 |
80 | MP0005387_immune_system_phenotype | 1.05168510 |
81 | MP0002398_abnormal_bone_marrow | 1.02711420 |
82 | MP0002722_abnormal_immune_system | 1.01679774 |
83 | MP0001958_emphysema | 0.98065030 |
84 | MP0003828_pulmonary_edema | 0.97806933 |
85 | MP0010352_gastrointestinal_tract_polyps | 0.96429640 |
86 | MP0005666_abnormal_adipose_tissue | 0.96333881 |
87 | MP0002429_abnormal_blood_cell | 0.96191206 |
88 | MP0003634_abnormal_glial_cell | 0.95936874 |
89 | MP0005397_hematopoietic_system_phenotyp | 0.95704715 |
90 | MP0001545_abnormal_hematopoietic_system | 0.95704715 |
91 | MP0005360_urolithiasis | 0.95585585 |
92 | MP0002896_abnormal_bone_mineralization | 0.95555996 |
93 | MP0005164_abnormal_response_to | 0.94388924 |
94 | MP0001853_heart_inflammation | 0.93464696 |
95 | MP0005085_abnormal_gallbladder_physiolo | 0.92732204 |
96 | MP0003950_abnormal_plasma_membrane | 0.91703758 |
97 | MP0008874_decreased_physiological_sensi | 0.91438676 |
98 | MP0004947_skin_inflammation | 0.86819611 |
99 | MP0005390_skeleton_phenotype | 0.85958857 |
100 | MP0002166_altered_tumor_susceptibility | 0.84092727 |
101 | MP0001849_ear_inflammation | 0.83392877 |
102 | MP0009763_increased_sensitivity_to | 0.82754794 |
103 | MP0003186_abnormal_redox_activity | 0.81883746 |
104 | MP0004019_abnormal_vitamin_homeostasis | 0.81213806 |
105 | MP0003453_abnormal_keratinocyte_physiol | 0.79784927 |
106 | MP0010155_abnormal_intestine_physiology | 0.78965633 |
107 | MP0000371_diluted_coat_color | 0.77907723 |
108 | MP0005319_abnormal_enzyme/_coenzyme | 0.76866134 |
109 | MP0010386_abnormal_urinary_bladder | 0.75867702 |
110 | MP0000604_amyloidosis | 0.74820444 |
111 | MP0002060_abnormal_skin_morphology | 0.74049768 |
112 | MP0008438_abnormal_cutaneous_collagen | 0.72763541 |
113 | MP0004130_abnormal_muscle_cell | 0.70992729 |
114 | MP0003638_abnormal_response/metabolism_ | 0.68609251 |
115 | MP0000609_abnormal_liver_physiology | 0.67995219 |
116 | MP0001243_abnormal_dermal_layer | 0.67952583 |
117 | MP0005647_abnormal_sex_gland | 0.67910751 |
118 | MP0003091_abnormal_cell_migration | 0.67279362 |
119 | MP0002136_abnormal_kidney_physiology | 0.67254580 |
120 | MP0003795_abnormal_bone_structure | 0.67250209 |
121 | MP0002933_joint_inflammation | 0.67220803 |
122 | MP0005595_abnormal_vascular_smooth | 0.65956209 |
123 | MP0000858_altered_metastatic_potential | 0.64819934 |
124 | MP0005197_abnormal_uvea_morphology | 0.63040080 |
125 | MP0001873_stomach_inflammation | 0.61825992 |
126 | MP0004808_abnormal_hematopoietic_stem | 0.60807705 |
127 | MP0004484_altered_response_of | 0.57667097 |
128 | MP0003448_altered_tumor_morphology | 0.57109403 |
129 | MP0010307_abnormal_tumor_latency | 0.56179530 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glomerulonephritis (HP:0000099) | 9.40366806 |
2 | Complement deficiency (HP:0004431) | 7.34644216 |
3 | Arterial tortuosity (HP:0005116) | 6.13173058 |
4 | Mutism (HP:0002300) | 5.66869488 |
5 | Increased cerebral lipofuscin (HP:0011813) | 5.65605056 |
6 | Dysostosis multiplex (HP:0000943) | 5.44880434 |
7 | Cerebral aneurysm (HP:0004944) | 5.43352998 |
8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.42668971 |
9 | Vascular tortuosity (HP:0004948) | 5.40926932 |
10 | Abnormality of complement system (HP:0005339) | 5.36399178 |
11 | Retinal atrophy (HP:0001105) | 5.18745812 |
12 | Nephritis (HP:0000123) | 4.66470959 |
13 | Recurrent abscess formation (HP:0002722) | 4.25217113 |
14 | Hematochezia (HP:0002573) | 4.23219756 |
15 | Aortic aneurysm (HP:0004942) | 4.22863368 |
16 | Recurrent bacterial skin infections (HP:0005406) | 4.22401280 |
17 | Urethral obstruction (HP:0000796) | 4.20889845 |
18 | Mucopolysacchariduria (HP:0008155) | 4.08017538 |
19 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.08017538 |
20 | Axonal loss (HP:0003447) | 3.99885037 |
21 | Disinhibition (HP:0000734) | 3.89186472 |
22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.83828350 |
23 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.83828350 |
24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.83828350 |
25 | Agnosia (HP:0010524) | 3.77122909 |
26 | Vertebral compression fractures (HP:0002953) | 3.71856637 |
27 | Eczematoid dermatitis (HP:0000976) | 3.70452119 |
28 | Vacuolated lymphocytes (HP:0001922) | 3.69965138 |
29 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.52470382 |
30 | Neurofibrillary tangles (HP:0002185) | 3.47415836 |
31 | Neuronal loss in central nervous system (HP:0002529) | 3.45402452 |
32 | Striae distensae (HP:0001065) | 3.41612174 |
33 | Disproportionate tall stature (HP:0001519) | 3.40492915 |
34 | Upper motor neuron abnormality (HP:0002127) | 3.26350765 |
35 | Aortic dissection (HP:0002647) | 3.25831207 |
36 | Nuclear cataract (HP:0100018) | 3.19632870 |
37 | Colitis (HP:0002583) | 3.09865108 |
38 | Abnormal platelet function (HP:0011869) | 2.91300921 |
39 | Impaired platelet aggregation (HP:0003540) | 2.91300921 |
40 | Spondylolisthesis (HP:0003302) | 2.91023259 |
41 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.80118047 |
42 | Premature rupture of membranes (HP:0001788) | 2.72441270 |
43 | Amyloidosis (HP:0011034) | 2.68625414 |
44 | * Abnormality of glycolipid metabolism (HP:0010969) | 2.67891162 |
45 | * Abnormality of liposaccharide metabolism (HP:0010968) | 2.67891162 |
46 | * Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.67891162 |
47 | Pathologic fracture (HP:0002756) | 2.65210054 |
48 | Cerebral inclusion bodies (HP:0100314) | 2.63398905 |
49 | Purpura (HP:0000979) | 2.58465588 |
50 | Arnold-Chiari malformation (HP:0002308) | 2.54690159 |
51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44015817 |
52 | Polygenic inheritance (HP:0010982) | 2.43346848 |
53 | Mitral valve prolapse (HP:0001634) | 2.41945894 |
54 | Abnormality of macrophages (HP:0004311) | 2.40391850 |
55 | Rectal fistula (HP:0100590) | 2.39092103 |
56 | Rectovaginal fistula (HP:0000143) | 2.39092103 |
57 | Prolonged neonatal jaundice (HP:0006579) | 2.36094953 |
58 | Inflammation of the large intestine (HP:0002037) | 2.35780823 |
59 | Recurrent skin infections (HP:0001581) | 2.30789030 |
60 | J-shaped sella turcica (HP:0002680) | 2.27701607 |
61 | Basal ganglia calcification (HP:0002135) | 2.26242069 |
62 | Xanthomatosis (HP:0000991) | 2.25687652 |
63 | Joint stiffness (HP:0001387) | 2.25476412 |
64 | Thoracic kyphosis (HP:0002942) | 2.25084122 |
65 | Autoimmune thrombocytopenia (HP:0001973) | 2.24599330 |
66 | Intestinal fistula (HP:0100819) | 2.24307298 |
67 | Partial duplication of thumb phalanx (HP:0009944) | 2.23884372 |
68 | Dementia (HP:0000726) | 2.23144872 |
69 | Protrusio acetabuli (HP:0003179) | 2.22397796 |
70 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.19573156 |
71 | Increased serum ferritin (HP:0003281) | 2.18213354 |
72 | Gastrointestinal inflammation (HP:0004386) | 2.17419880 |
73 | Vaginal fistula (HP:0004320) | 2.16583734 |
74 | * Progressive neurologic deterioration (HP:0002344) | 2.16546540 |
75 | Inappropriate behavior (HP:0000719) | 2.16045259 |
76 | Cervical subluxation (HP:0003308) | 2.13619370 |
77 | Postural instability (HP:0002172) | 2.12612506 |
78 | Asymmetric septal hypertrophy (HP:0001670) | 2.10971064 |
79 | Mediastinal lymphadenopathy (HP:0100721) | 2.09793098 |
80 | Split foot (HP:0001839) | 2.06681678 |
81 | Lower limb asymmetry (HP:0100559) | 2.05944256 |
82 | Intestinal atresia (HP:0011100) | 2.03922805 |
83 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.03891061 |
84 | Tetraparesis (HP:0002273) | 2.00620906 |
85 | Systemic lupus erythematosus (HP:0002725) | 10.9595208 |
86 | Increased CSF protein (HP:0002922) | 1.98876559 |
87 | Metaphyseal irregularity (HP:0003025) | 1.98583729 |
88 | * Hepatosplenomegaly (HP:0001433) | 1.97890839 |
89 | Myositis (HP:0100614) | 1.95512565 |
90 | * Cardiomegaly (HP:0001640) | 1.94377523 |
91 | Obstructive lung disease (HP:0006536) | 1.94270892 |
92 | Chronic obstructive pulmonary disease (HP:0006510) | 1.94270892 |
93 | Malnutrition (HP:0004395) | 1.94099486 |
94 | Bicuspid aortic valve (HP:0001647) | 1.94098045 |
95 | Apathy (HP:0000741) | 1.94018112 |
96 | Orchitis (HP:0100796) | 1.93534012 |
97 | Partial duplication of the phalanx of hand (HP:0009999) | 1.92475118 |
98 | Petechiae (HP:0000967) | 1.91978456 |
99 | Skin nodule (HP:0200036) | 1.91434910 |
100 | Peripheral demyelination (HP:0011096) | 1.90800955 |
101 | Conjunctival telangiectasia (HP:0000524) | 1.90738552 |
102 | Exotropia (HP:0000577) | 1.90141046 |
103 | Progressive visual loss (HP:0000529) | 1.84101189 |
104 | Loss of speech (HP:0002371) | 1.84075764 |
105 | Beaking of vertebral bodies (HP:0004568) | 1.82935720 |
106 | Global brain atrophy (HP:0002283) | 1.82504095 |
107 | Camptodactyly of toe (HP:0001836) | 1.82099905 |
108 | Gingivitis (HP:0000230) | 1.82037036 |
109 | Diminished motivation (HP:0000745) | 1.80408645 |
110 | Mitral stenosis (HP:0001718) | 1.79695158 |
111 | Thickened calvaria (HP:0002684) | 1.78173423 |
112 | Interstitial pulmonary disease (HP:0006530) | 1.77708285 |
113 | Polycythemia (HP:0001901) | 1.76758209 |
114 | Clumsiness (HP:0002312) | 1.76423600 |
115 | Ovoid vertebral bodies (HP:0003300) | 1.75666097 |
116 | Protuberant abdomen (HP:0001538) | 1.73874984 |
117 | Personality changes (HP:0000751) | 1.72649349 |
118 | Achilles tendon contracture (HP:0001771) | 1.69762856 |
119 | Abnormality of iron homeostasis (HP:0011031) | 1.68480288 |
120 | Spontaneous hematomas (HP:0007420) | 1.68056373 |
121 | Myocardial infarction (HP:0001658) | 1.67100809 |
122 | Bone pain (HP:0002653) | 1.66331178 |
123 | Bone cyst (HP:0012062) | 1.66019346 |
124 | Cellulitis (HP:0100658) | 1.65325946 |
125 | Supranuclear gaze palsy (HP:0000605) | 1.64641560 |
126 | Rapidly progressive (HP:0003678) | 1.64543061 |
127 | Abnormality of the periventricular white matter (HP:0002518) | 1.64140945 |
128 | Spinal muscular atrophy (HP:0007269) | 1.63907706 |
129 | IgM deficiency (HP:0002850) | 1.62861778 |
130 | Abnormality of the Achilles tendon (HP:0005109) | 1.62835778 |
131 | Deep venous thrombosis (HP:0002625) | 1.62463657 |
132 | Abnormality of the lumbar spine (HP:0100712) | 1.61638730 |
133 | Sensorimotor neuropathy (HP:0007141) | 1.61223841 |
134 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.61201891 |
135 | Osteolytic defects of the hand bones (HP:0009699) | 1.61142232 |
136 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.61142232 |
137 | Aneurysm (HP:0002617) | 1.60738190 |
138 | Obstructive sleep apnea (HP:0002870) | 1.60572074 |
139 | Hypoplasia of the odontoid process (HP:0003311) | 1.60353373 |
140 | Mucosal telangiectasiae (HP:0100579) | 1.59813454 |
141 | Pulmonary infiltrates (HP:0002113) | 1.59773426 |
142 | Esophageal neoplasm (HP:0100751) | 1.58726710 |
143 | Neoplasm of head and neck (HP:0012288) | 1.58726710 |
144 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.58231068 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TGFBR2 | 9.06127684 |
2 | MAPK15 | 5.74574605 |
3 | GRK7 | 4.18011625 |
4 | CSF1R | 3.89803512 |
5 | NME2 | 3.44427921 |
6 | TSSK6 | 3.23937225 |
7 | PDK2 | 2.49890161 |
8 | TYK2 | 2.49474179 |
9 | PAK4 | 2.32541893 |
10 | DDR2 | 2.12194016 |
11 | RIPK1 | 2.08331033 |
12 | RIPK4 | 1.98106360 |
13 | TESK1 | 1.96731478 |
14 | TAOK2 | 1.87267567 |
15 | PIM2 | 1.79660784 |
16 | PRPF4B | 1.78215873 |
17 | STK10 | 1.77218372 |
18 | ABL2 | 1.72377288 |
19 | CAMK1D | 1.71625860 |
20 | MATK | 1.60265028 |
21 | MOS | 1.59015848 |
22 | BLK | 1.57746302 |
23 | PDGFRA | 1.57542097 |
24 | TBK1 | 1.56729807 |
25 | ERN1 | 1.54179145 |
26 | VRK1 | 1.48816381 |
27 | BMPR2 | 1.45058936 |
28 | IRAK4 | 1.45018590 |
29 | TESK2 | 1.44602410 |
30 | MAPK12 | 1.44366049 |
31 | PKN2 | 1.38044802 |
32 | JAK1 | 1.37616118 |
33 | CLK1 | 1.32043677 |
34 | NEK9 | 1.31006324 |
35 | LIMK1 | 1.30677635 |
36 | MAP3K11 | 1.28204294 |
37 | MST1R | 1.27524917 |
38 | CAMK1G | 1.19003266 |
39 | IRAK3 | 1.18543625 |
40 | MAP4K1 | 1.17645921 |
41 | TTN | 1.17303291 |
42 | ZAP70 | 1.16858061 |
43 | MAP3K9 | 1.15577939 |
44 | MYLK | 1.15216140 |
45 | CAMKK2 | 1.12455821 |
46 | MAPK7 | 1.09876750 |
47 | CDC42BPA | 1.09341401 |
48 | GRK5 | 1.06727671 |
49 | MAP3K1 | 1.03420455 |
50 | KIT | 1.01802559 |
51 | EEF2K | 1.01546911 |
52 | PAK2 | 1.01196992 |
53 | HCK | 1.00589989 |
54 | MAP3K12 | 0.98847763 |
55 | JAK2 | 0.97571501 |
56 | CSK | 0.94764820 |
57 | MAP2K3 | 0.94471415 |
58 | ACVR1B | 0.93860957 |
59 | CDK3 | 0.92431728 |
60 | EPHA2 | 0.90256589 |
61 | EPHB1 | 0.88161444 |
62 | TAOK1 | 0.87566629 |
63 | LATS2 | 0.86321057 |
64 | PDK1 | 0.86213839 |
65 | CAMKK1 | 0.85606045 |
66 | ITK | 0.85290383 |
67 | MAPKAPK3 | 0.84938697 |
68 | ADRBK2 | 0.84472534 |
69 | ERBB4 | 0.79676308 |
70 | PRKG2 | 0.79387318 |
71 | IKBKB | 0.78305444 |
72 | FES | 0.77608586 |
73 | LYN | 0.75976371 |
74 | MAP3K5 | 0.74025368 |
75 | PTK2 | 0.73426324 |
76 | SIK1 | 0.71904709 |
77 | LCK | 0.71786076 |
78 | MAP3K2 | 0.70918762 |
79 | MAPKAPK5 | 0.66609048 |
80 | EPHB2 | 0.62460932 |
81 | TRIB3 | 0.62083805 |
82 | MAPKAPK2 | 0.61623076 |
83 | CDK6 | 0.60865232 |
84 | PIK3CG | 0.60642504 |
85 | SCYL2 | 0.58951820 |
86 | PTK6 | 0.57638207 |
87 | IGF1R | 0.57296304 |
88 | CAMK4 | 0.56834610 |
89 | TIE1 | 0.56630195 |
90 | PDPK1 | 0.56394873 |
91 | SYK | 0.56144231 |
92 | TXK | 0.55902216 |
93 | MAP3K14 | 0.55795163 |
94 | KDR | 0.52294556 |
95 | PDGFRB | 0.50873095 |
96 | PBK | 0.50831222 |
97 | LMTK2 | 0.50175312 |
98 | GSK3A | 0.49267958 |
99 | FGFR4 | 0.45369526 |
100 | ARAF | 0.43968949 |
101 | NEK6 | 0.43263966 |
102 | DAPK3 | 0.43034430 |
103 | MAP3K13 | 0.42869828 |
104 | MAP3K3 | 0.42136460 |
105 | CHUK | 0.40076569 |
106 | BTK | 0.39300979 |
107 | MET | 0.37693082 |
108 | FER | 0.37120877 |
109 | MAPK4 | 0.37077972 |
110 | MAP2K2 | 0.36641060 |
111 | INSR | 0.35618800 |
112 | PRKD2 | 0.34890756 |
113 | SIK2 | 0.34363530 |
114 | CDK8 | 0.34130734 |
115 | RPS6KA2 | 0.33873143 |
116 | SMG1 | 0.32649525 |
117 | FLT3 | 0.32637143 |
118 | ICK | 0.32616286 |
119 | EGFR | 0.30903891 |
120 | MAP3K10 | 0.30330469 |
121 | RET | 0.29335339 |
122 | STK11 | 0.28785129 |
123 | MARK3 | 0.28579433 |
124 | FGR | 0.28129043 |
125 | EIF2AK2 | 0.27634495 |
126 | RPS6KA4 | 0.26384599 |
127 | MELK | 0.25670129 |
128 | TRPM7 | 0.25407691 |
129 | IKBKE | 0.25305097 |
130 | PRKD1 | 0.24840907 |
131 | KSR2 | 0.23520654 |
132 | RPS6KA6 | 0.19563754 |
133 | IRAK2 | 0.19347513 |
134 | RPS6KC1 | 0.19038698 |
135 | RPS6KL1 | 0.19038698 |
136 | PRKAA2 | 0.19011712 |
137 | MAP3K6 | 0.18267918 |
138 | ABL1 | 0.17696279 |
139 | FGFR3 | 0.15889526 |
140 | PRKCD | 0.14841800 |
141 | JAK3 | 0.14081873 |
142 | MAP3K8 | 0.12522380 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.58121918 |
2 | * Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.54034222 |
3 | * Lysosome_Homo sapiens_hsa04142 | 3.42517966 |
4 | * Other glycan degradation_Homo sapiens_hsa00511 | 3.13114297 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.06009317 |
6 | Prion diseases_Homo sapiens_hsa05020 | 3.05447807 |
7 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 2.58700858 |
8 | Pertussis_Homo sapiens_hsa05133 | 2.53583815 |
9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.39868463 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.36026540 |
11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.34587366 |
12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.94472161 |
13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.80292220 |
14 | Asthma_Homo sapiens_hsa05310 | 1.80024452 |
15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.73050998 |
16 | Allograft rejection_Homo sapiens_hsa05330 | 1.65155862 |
17 | Tuberculosis_Homo sapiens_hsa05152 | 1.60777390 |
18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57905390 |
19 | Legionellosis_Homo sapiens_hsa05134 | 1.56998741 |
20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.55442426 |
21 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.51504154 |
22 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.49116426 |
23 | Galactose metabolism_Homo sapiens_hsa00052 | 1.48456629 |
24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.44132471 |
25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38359022 |
26 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.37924329 |
27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37538438 |
28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.37347612 |
29 | * Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.37173881 |
30 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.30670321 |
31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.30466880 |
32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.27742202 |
33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.26690544 |
34 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.26060377 |
35 | * Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.24769034 |
36 | Bladder cancer_Homo sapiens_hsa05219 | 1.24690536 |
37 | Platelet activation_Homo sapiens_hsa04611 | 1.21905178 |
38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.17166187 |
39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14139037 |
40 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12889923 |
41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12100781 |
42 | Endocytosis_Homo sapiens_hsa04144 | 1.11637411 |
43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.11635508 |
44 | Colorectal cancer_Homo sapiens_hsa05210 | 1.11421032 |
45 | Influenza A_Homo sapiens_hsa05164 | 1.09462289 |
46 | Measles_Homo sapiens_hsa05162 | 1.07519823 |
47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.06717321 |
48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.06530747 |
49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04723058 |
50 | Salmonella infection_Homo sapiens_hsa05132 | 1.04570049 |
51 | Phagosome_Homo sapiens_hsa04145 | 1.01882742 |
52 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.99699549 |
53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97722253 |
54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.96475335 |
55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96278227 |
56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95984168 |
57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95643491 |
58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92337849 |
59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91336831 |
60 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.87613226 |
61 | Apoptosis_Homo sapiens_hsa04210 | 0.87055963 |
62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85471183 |
63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84492708 |
64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83982851 |
65 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.83205139 |
66 | Hepatitis B_Homo sapiens_hsa05161 | 0.81539905 |
67 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.78702055 |
68 | Malaria_Homo sapiens_hsa05144 | 0.78037083 |
69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.77450794 |
70 | ABC transporters_Homo sapiens_hsa02010 | 0.75822474 |
71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73047017 |
72 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68997502 |
73 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67951059 |
74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.67814531 |
75 | Adherens junction_Homo sapiens_hsa04520 | 0.65098162 |
76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64819166 |
77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63632852 |
78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63302138 |
79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62569864 |
80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61373486 |
81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60902322 |
82 | Shigellosis_Homo sapiens_hsa05131 | 0.60597511 |
83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60563932 |
84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59095349 |
85 | Renin secretion_Homo sapiens_hsa04924 | 0.58974283 |
86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57377802 |
87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56774772 |
88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54711500 |
89 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54611219 |
90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54412140 |
91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52457310 |
92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52385070 |
93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52367989 |
94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51919902 |
95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51478037 |
96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51072179 |
97 | Amoebiasis_Homo sapiens_hsa05146 | 0.48932010 |
98 | Salivary secretion_Homo sapiens_hsa04970 | 0.48140973 |
99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47273125 |
100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46428799 |
101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46047960 |
102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45830845 |
103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44927769 |
104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44882271 |
105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44827746 |
106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44780761 |
107 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.44172444 |
108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42902014 |
109 | Glioma_Homo sapiens_hsa05214 | 0.42105974 |
110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41035831 |
111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40898486 |
112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40029692 |
113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38504690 |
114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38391561 |
115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37403579 |
116 | Mineral absorption_Homo sapiens_hsa04978 | 0.34722238 |
117 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.34549881 |
118 | Carbon metabolism_Homo sapiens_hsa01200 | 0.34421091 |
119 | Focal adhesion_Homo sapiens_hsa04510 | 0.33658421 |
120 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.33242412 |
121 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32876155 |
122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32443981 |
123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31341700 |
124 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.30651169 |
125 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.29945560 |
126 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.29258124 |
127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29164101 |
128 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.28712570 |
129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28641916 |
130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28452594 |
131 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.28256669 |
132 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28105016 |
133 | Hepatitis C_Homo sapiens_hsa05160 | 0.26529472 |
134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.25959766 |
135 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.25285729 |
136 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.24780332 |
137 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24584537 |
138 | Insulin resistance_Homo sapiens_hsa04931 | 0.23694568 |